Effect of cyclin G2 on proliferative ability of SGC-7901 cell

来源 :世界胃肠病学杂志(英文版) | 被引量 : 0次 | 上传用户:zz9506018
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
AIM: To study the effect of oydin G2 on proliferation of gastric adenocarcinoma cell line-SGC-7901 cellin vitro.METHODS: By use of cation lipofectamine transfection reagent,the pIRES-G2 and pIRESneo plasmids were transferred into SGC-7901cell line. Anticlones were selected by G418. Positive clones were observed and counted using Giemsa staining.Cell proliferative ability was assayed by MTT.RESULTS: (1) The done number of pIRES-G2 group decreased,clone volume reduced. The number of cell dones in pIRESneo group was 87±3, that of pIRES-G2 group was 53±4,occupying 60.1% of pIRESneo group, there was significant difference obviously (P<0.01, t=-15.45). (2) The average absorbance of clone cell obtained by stable transfection of pIRES-G2 at 570 nm was 1.6966±0.2125, the average absorbance of clone cell obtained by stable transfection of pIRESneo at 570 nm was 2.1182±0.3675, there was significant difference between them (P<0.01, t=3.412).CONCLUSION: Cydin G2 can inhibit SGC-7901cell proliferative ability obviously, it may be a negative regulator in cell cycle regulation.
其他文献
期刊
AIM: To investigate the serum erythropoietin (Epo) levels in patients with chronic liver diseases and to compare to subjects with iron-deficiency anaemia and he
【摘要】 目的 观察维拉帕米二甲双胍联合用药对高血压合并2型糖尿病(diabetes mellitus,DM)患者降压及降糖作用。方法 将129例高血压合并2型DM患者分为2组,维拉帕米治疗组98例,对照组31例。(1)维拉帕米治疗组:盐酸维拉帕米缓释胶囊180 mg/d,二甲双胍750~1 500 mg/d,缬沙坦80~160 mg/d,阿司匹林100 mg/d;(2)对照组,缬沙坦80~160
目的:研究分析护理配合在急诊心脏复苏术对心脏骤停患者抢救中的临床效果.方法随机抽选2015年1月-2017年12月我院接收并予以心脏复苏手术治疗的心脏骤停患者50例,按入院接受
期刊
期刊
期刊
期刊
【摘要】 目的 评估新辅助化疗联合高-低氧吸入放射治疗浸润性膀胱癌的疗效及安全性。方法 对31 例无法耐受或拒绝接受膀胱全切手术的浸润性膀胱癌患者进行保留膀胱治疗,先给予新辅助化疗2周期,然后给予盆腔适形放疗,放疗过程中先后吸入高低浓度氧。对肿瘤部分缓解及复发患者行保留膀胱的手术。结果 肿瘤完全缓解率为71.0%(22/31),部分缓解率29.0 %(9/31)。9例部分缓解的患者接受了保留膀胱的
儿科麻醉的特殊之处在于,儿童主诉不清,对于麻醉引起的多种反应无法准确表达;儿童全身各项系统发育尚未成熟,对麻醉工作提出了很大的挑战.随着麻醉技术的快速发展,麻醉已能常
期刊